Clinical trials
Obesity trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 12 |
| Unknown status | 7 |
| Not yet recruiting | 5 |
| Active, not recruiting | 3 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 13 |
| Chinese University of Hong Kong | 10 |
| Amgen | 5 |
| The Hong Kong Polytechnic University | 3 |
| Novo Nordisk A/S | 2 |
| Sanofi | 2 |
| Asia Diabetes Foundation | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Galmed Research and Development, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 44 |
| Overweight | 14 |
| Diabetes Mellitus, Type 2 | 7 |
| Weight Loss | 6 |
| Diabetes Mellitus | 5 |
| Glucose Intolerance | 3 |
| Metabolic Syndrome | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Obesity, Abdominal | 3 |
| Dyslipidemias | 2 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.